Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

ClinicalTrials.gov ID: NCT05063539

Public ClinicalTrials.gov record NCT05063539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 4:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease

Study identification

NCT ID
NCT05063539
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
327 participants

Conditions and interventions

Interventions

  • LY3372689 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
60 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2021
Primary completion
Jul 8, 2024
Completion
May 21, 2025
Last update posted
Jul 27, 2025

2021 – 2025

United States locations

U.S. sites
35
U.S. states
11
U.S. cities
33
Facility City State ZIP Site status
Hope Clinical Research, Inc. Canoga Park California 91303
Neuro-Pain Medical Center Fresno California 93710
Irvine Clinical Research Irvine California 92614
Sharp Mesa Vista Hospital San Diego California 92123
Institute for Neurodegenerative Disorders New Haven Connecticut 06510
JEM Research Institute Atlantis Florida 33462
VIN-Julie Schwartzbard Aventura Florida 33180
Neurology Offices of South Florida Boca Raton Florida 33428
Brain Matters Research Delray Beach Florida 33445
Neuropsychiatric Research Center of Southwest Florida Fort Myers Florida 33912
K2 Medical Research Maitland Florida 32751
ClinCloud - Viera Melbourne Florida 32940
Merritt Island Medical Research, LLC Merritt Island Florida 32952
VIN-Andrew Lerman Miami Florida 33133
IMIC, Inc. Miami Florida 33176
VIN-Victor Faradji Miami Florida 33176
Suncoast Clinical Research, Inc. New Port Richey Florida 34652
Renstar Medical Research Ocala Florida 34470
VIN- Margarita Almeida El-Ramey Pembroke Pines Florida 33026
Brain Matters Research Stuart Florida 34997
Charter Research - Lady Lake The Villages Florida 32162
Josephson Wallack Munshower Neurology, PC Indianapolis Indiana 46256
Boston Center for Memory Newton Massachusetts 02459
Donald S. Marks M.D., P.C. Plymouth Massachusetts 02360
MedVadis Research Corporation Waltham Massachusetts 02451
Adams Clinical Watertown Massachusetts 02472
The Cognitive and Research Center of New Jersey Springfield New Jersey 07081
Advanced Memory Research Institute of New Jersey Toms River New Jersey 08755
University at Buffalo - UBMD Neurology Buffalo New York 14203
Abington Neurological Associates, Ltd. Abington Pennsylvania 19001
Keystone Clinical Studies Plymouth Meeting Pennsylvania 19462
Rhode Island Mood & Memory Research Institute East Providence Rhode Island 02914
Kerwin Medical Center Dallas Texas 75231
The University of Texas Health Science Center at Houston Houston Texas 77054
The Memory Clinic Bennington Vermont 05201-9810

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05063539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2025 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05063539 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →